Search the Newsreel

Chicago Atlantic BDC Q2 Earnings Call Highlights

Chicago Atlantic BDC reported Q2 net investment income of $7.7 million ($0.34 per share), a decrease from the previous quarter, largely due to loan repayments exceeding new originations and a smaller investment portfolio. Despite the decline, the company maintained its quarterly dividend at $0.34 …

Turkcell (NYSE: TKC) Q2 2026: 5G capex surges as margins tighten

Turkcell reported Q2 2026 revenue of TRY 71.8 billion, a 2.5% year-on-year increase under hyperinflation accounting, with net income declining by 5.7% to TRY 5.2 billion. The company experienced tightened margins due to significant 5G investments, including a USD 1.2 billion license, which also …

Outlook Therapeutics (OTLK) Q3 Earnings Miss Highlight Valuation Challenges

Why STLLR Gold Inc. stock fell yesterday

Outlook Therapeutics, Inc. (OTLK) Reports Q3 Loss, Lags Revenue Estimates

Outlook Therapeutics, Inc. (OTLK) reported a Q3 loss of $0.09 per share, aligning with analyst expectations, but missed revenue estimates significantly with $0.01 million compared to an expected $1.5 million. The company's stock has underperformed the S&P 500 this year, and while the current …

Kayne Anderson Rudnick (NASDAQ: OLLI) reports 1.6% beneficial stake in Ollie’s

Kayne Anderson Rudnick Investment Management, LLC has filed an amended beneficial ownership report for Ollie's Bargain Outlet Holdings Inc (OLLI), disclosing a 1.6% beneficial stake. The firm owns 974,819 shares of common stock as of June 30, 2026, with detailed allocations for sole and …

GTLB|GitLab Inc|Price:43.375|Chg%:+2.565

InvestingPro’nun gerçeğe uygun değer tahmini Platform Turizm’de %59 kazandırdı

FitLife Brands (FTLF) Surges 9.06% as Shares Approach Key Resistance at $11.75 - Demand Zone

FDA-approved LYTENAVA targets wet AMD; U.S. launch planned by year-end 2026

Outlook Therapeutics (OTLK) reported a Q3 fiscal 2026 net loss of $20.3 million but highlighted the FDA approval of LYTENAVA™ (bevacizumab-vikg) for wet age-related macular degeneration, the only FDA-approved ophthalmic bevacizumab for this condition. The company is preparing for a U.S. launch by year-end …

Outlook Therapeutics Reports Third Quarter Fiscal Year 2026 Financial Results and Provides Business Update Highlighting FDA Approval of LYTENAVA™

Outlook Therapeutics reported its third-quarter fiscal year 2026 financial results, highlighting the FDA approval of LYTENAVA™ for wet age-related macular degeneration (wet AMD). The company is preparing for a U.S. commercial launch by the end of 2026, with an estimated potential to exceed $500 …

Swiss Life Asset Management Ltd Acquires 21,054 Shares of Crown Castle Inc. $CCI

Swiss Life Asset Management Ltd significantly increased its stake in Crown Castle Inc. (NYSE:CCI) by 21.3% in the second quarter, acquiring an additional 21,054 shares to reach a total holding of 119,868 shares valued at $9.08 million. The article notes that Crown Castle has …

iA Global Asset Management Inc. Purchases New Shares in Crown Castle Inc. $CCI

iA Global Asset Management Inc. has acquired 19,312 shares of Crown Castle Inc. (NYSE:CCI) in the second quarter, valued at approximately $1.46 million. This purchase is part of broader institutional investment trends, with major firms like Vanguard Group Inc. and Cohen & Steers Inc. …

Gitlab Inc (GTLB) News, Articles, Events & Latest Updates

Chipotle Mexican Grill to launch first Saudi outlet in Riyadh

Chipotle Mexican Grill is set to open its first restaurant in Riyadh, Saudi Arabia, later this month, marking its entry into the Saudi market. This expansion is part of an ongoing partnership with Alshaya Group, which has already helped Chipotle open 16 restaurants in …

Broad Bay Capital (BATRA) discloses 2.0M-share Atlanta Braves Series C position

MetLife (MET) details $13.1M in Form 13F holdings in combination report

MetLife Inc. (MET) has filed a Form 13F Combination Report detailing its equity holdings. The report summarizes 6 portfolio entries with an aggregate reported value of $13,089,220, representing Section 13(f) securities managed by its investment subsidiaries. MetLife clarifies that it disclaims direct investment discretion, …

TKC5983608 Bond Coupon Profile — Rate & Payments

This article provides the coupon profile for the TKC5983608 bond issued by Turkcell Iletisim Hizmetleri A.S. It details the current coupon rate of 7.65% and notes the next payment is scheduled for January 25, 2027. The article also highlights features available for researching bond …

GO|Grocery Outlet Holding Corp|Price:10.755|Chg%:+0.585

Crown Castle Inc. $CCI is Cooke & Bieler LP's 6th Largest Position

Cooke & Bieler LP has maintained Crown Castle Inc. ($CCI) as its sixth-largest position despite trimming its stake by 1% in the second quarter. Institutional ownership of CCI remains high at 90.77%, with several major firms increasing their holdings. Crown Castle offers a quarterly …

Atlantic Union Bankshares Co. (NYSE:AUB) Given Average Recommendation of "Moderate Buy" by Analysts

Westlake (WLK) Stock Looks About Right On A 35% Slide

Westlake (WLK) stock has seen a 35% decline over the past three years, but its current valuation, based on P/S ratio and market multiples, suggests it is now trading in a fair range. The company's future cash generation potential supports the current share price, …

OTLK|Outlook Therapeutics Inc|Price:0.691|Chg%:+0.018

Bechtle AG: Konsensus der Analysten und Kursziel | 515870 | DE0005158703

HOROZ LOJISTIK Hisse Senedi Canlı Grafik

Nestlé S.A.: Konsensus der Analysten und Kursziel | A0Q4DC | CH0038863350

METROPAL KURUMSAL HIZMETLER (MCARD) Hisse Senedi

SEYITLER KIMYA (SEYKM) Hisse Senedi

Atlanticus (ATLC) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 5:00 p.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Jeffrey HowardChief Financial Officer - William McCamey TAKEAWAYS Total Operating Revenue and Other Income -- $744.3 million, an 89% increase from the …

Atlanticus (ATLC) Is Down 13.2% After Q2 Earnings Beat And Faster Mercury Integration Progress – Has The Bull Case Changed?

The Top 5 Analyst Questions From Remitly’s Q2 Earnings Call

The Top 5 Analyst Questions From Remitly's Q2 Earnings Call Remitly's second quarter was marked by strong customer growth and broad product momentum, leading to results that surpassed Wall Street expectations and a significant positive market reaction. Management pointed to robust execution in both …

Little Green Pharma (ASX:LGP)Hits Record Revenue as Europe Overtakes the Home Market

Outlook Therapeutics Q3 Results: Loss narrows to 8 cents per share

Grocery Outlet (GO) Stock Jumps On Early Turnaround Signs And Debt Risk

Grocery Outlet (GO) stock jumped 6% after its Q2 earnings showed adjusted EPS and EBITDA ahead of outlook, suggesting an early turnaround. Despite this, the company faces ongoing challenges including declining same-store sales and a significant debt load of US$506 million. The market is …

Outlook Therapeutics Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most

Eilmeldung: Analysten haben ihre Prognosen für die RTL Group S.A. (ETR:RRTL) gerade deutlich nach oben korrigiert